Bharat Parenterals Ltd is in the business of manufacturing and marketing of formulationsBusiness Overview: BPL is a Gujarat-based WHO GMP & an ISO 10002: 2014, 9001: 2015 certified pharmaceutical company. It manufactures over 800 products spread over 20+ different categories including General Products, β-Lactum/ Cephalosporin Products, Formulations in the form...
Bharat Parenterals Limited has announced its 33rd Annual General Meeting (AGM), scheduled for Saturday, September 19, 2026, at 11:00 a.m. IST. The company will conduct this important shareholder engagement entirely through Video Conferencing or Other Audio-Visual Means. This virtual format ensures broader participation for investors. The AGM offers a crucial...
Bharat Parenterals Limited has sent letters to shareholders without registered email addresses, providing a web-link to the Annual Report for Financial Year 2025-26 and the Notice for the 33rd Annual General Meeting (AGM). The AGM is scheduled for Saturday, September 19, 2026, at 11:00 A.M. via Video Conferencing/Other Audio-Visual Means....
Bharat Parenterals Limited has fixed Saturday September 12, 2026, as the Record Date for determining shareholder entitlement to the dividend for the financial year 2025-26. Only shareholders holding shares as beneficial owners by the close of business on this date will be eligible for the dividend. This payment is contingent...
Notice of 33rd Annual General Meeting of the Company.
